Coronado Industries Announces European Sales and Distribution Meetings are Going Extremely Well; Expects to Finalize a Distribution Agreement With Italian Company.Business Editors/Health/Medical Writers FOUNTAIN HILLS, Ariz.--(BUSINESS WIRE)--June 11, 2003 Coronado Industries Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: CDIK), a manufacturer of proprietary pneumatic devices for the treatment of glaucoma, announces the European sales and distribution meetings are going extremely well. On June 3, 2003, Coronado announced G. Richard Smith, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , would be traveling to Europe to attend pre-arranged meetings with interested parties for the distribution of the company's patented "PNT PNT Point PNT Paint (MacPaint graphic file format) PNT Patient PNT Pentagon (Washington, DC; US DoD) PNT Positioning, Navigation and Timing PNT Prime Number Theorem PNT Phenytoin " device and with key European personnel who can significantly advance distribution efforts. Those meetings were pre-arranged by the company's newly appointed Director of Operations John W. Sharkey, Ph.D., and newly appointed Director of European Distribution Francesco Aspes, M.D. Smith reported, "I am extremely encouraged by the meetings I have been attending and feel the outcome of these meetings will have a very positive effect on the future of Coronado and its shareholders. I expect to finalize a distribution agreement with a well-known Italian company in the very near future. I am even more convinced that Dr. Sharkey's reputation and European contacts will be a key ingredient in the success of our company. There are some very exciting times ahead." About Coronado Industries Inc. Coronado Industries Inc., through its wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. Ophthalmic International, focuses on the development and testing of a patented procedure, Pneumatic Trabeculoplasty (PNT). PNT, a two-minute non-invasive procedure, is currently being evaluated as a cost-effective alternative for the treatment of the most common types of glaucoma: open angle and pigmentary. During PNT, a suction device is applied to the eye for two minutes with the intention of reducing intraocular pressure intraocular pressure n. The pressure of the intraocular fluid within the eye. intraocular pressure (in´tr . Forward-looking statements in this release are made pursuant to the "safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third-party suppliers and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion